Samuel M. Law
YOU?
Author Swipe
View article: Severe, refractory paraneoplastic aplastic anemia secondary to primary peritoneal carcinoma: a case report
Severe, refractory paraneoplastic aplastic anemia secondary to primary peritoneal carcinoma: a case report Open
View article: Table S4 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S4 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Tumorsphere formation of breast cancer cells with modified EMP2 levels
View article: Supplemental Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Supplemental Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Supplemental Methods
View article: Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Little is known about the role of epithelial membrane protein-2 (EMP2) in breast cancer development or progression. In this study, we tested the hypothesis that EMP2 may regulate the formation or self-renewal of breast cancer stem cells (B…
View article: Table S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Characteristics of 23 mammary and breast cancer cell lines.
View article: Figure S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Figure S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Anti-EMP2 mAbs reduce tumor load in two trials using MDA-MB-231 xenograft models.
View article: Figure S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Figure S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
EMP2 and ALDH1 staining in breast cancer
View article: Table S5 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S5 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Secondary tumor formation following anti-EMP2 therapy.
View article: Figure S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Figure S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Anti-EMP2 mAbs reduce tumor load in two trials using MDA-MB-231 xenograft models.
View article: Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Little is known about the role of epithelial membrane protein-2 (EMP2) in breast cancer development or progression. In this study, we tested the hypothesis that EMP2 may regulate the formation or self-renewal of breast cancer stem cells (B…
View article: Figure S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Figure S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Modulation of EMP2 produces transcriptomic changes in breast cancer.
View article: Figure S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Figure S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
EMP2 and ALDH1 staining in breast cancer
View article: Table S4 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S4 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Tumorsphere formation of breast cancer cells with modified EMP2 levels
View article: Supplemental Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Supplemental Data from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Supplemental Methods
View article: Table S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Selected functional pathways enriched with EMP2 mRNA based on TCGA data.
View article: Figure S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Figure S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Modulation of EMP2 produces transcriptomic changes in breast cancer.
View article: Table S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S1 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Selected functional pathways enriched with EMP2 mRNA based on TCGA data.
View article: Table S5 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S5 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Secondary tumor formation following anti-EMP2 therapy.
View article: Table S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Selected functional pathways affected by changes in EMP2 expression.
View article: Table S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S3 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Selected functional pathways affected by changes in EMP2 expression.
View article: Table S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
Table S2 from EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Characteristics of 23 mammary and breast cancer cell lines.
View article: Supply chain disruptions due to the SARS‐CoV‐2 pandemic lead to an unusual preanalytical error in measuring hemoglobin concentration in a large medical center
Supply chain disruptions due to the SARS‐CoV‐2 pandemic lead to an unusual preanalytical error in measuring hemoglobin concentration in a large medical center Open
Preanalytical errors are defined as those that occur prior to the testing process (e.g., test request, patient and specimen identification, specimen collection, transport, accessioning and processing) and represent 46–68% of all analytical…
View article: Premise and peril of Wnt signaling activation through GSK-3β inhibition
Premise and peril of Wnt signaling activation through GSK-3β inhibition Open
Wnt signaling pathways have been extensively studied in the context of several diseases, including cancer, coronary artery disease, and age-related disorders. β-Catenin plays a central role in the most studied Wnt pathways, the Wnt/β-caten…
View article: Cigarette smoking and glaucoma in the United States and in South Korea
Cigarette smoking and glaucoma in the United States and in South Korea Open
View article: EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells
EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells Open
Little is known about the role of epithelial membrane protein-2 (EMP2) in breast cancer development or progression. In this study, we tested the hypothesis that EMP2 may regulate the formation or self-renewal of breast cancer stem cells (B…
View article: Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model
Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model Open
This work demonstrates the effectiveness of EMP2 as a novel target in pathologic corneal neovascularization in an animal model and supports additional investigation into EMP2 antibody blockade as a potential new therapeutic option.
View article: The association between smoking and glaucoma in the United States population
The association between smoking and glaucoma in the United States population Open